Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.
about
Efficacy and safety of vardenafil in men with diabetes and erectile dysfunctionEfficacy and safety of vardenafil in men with diabetes and erectile dysfunctionPotency, selectivity, and consequences of nonselectivity of PDE inhibitionCurrent oral treatments for erectile dysfunction.Vardenafil treatment for erectile dysfunction.Erectile dysfunction - an update of current practice and future strategies.Update on oral treatments for male erectile dysfunction.Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction.Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor.Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase.A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa.Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.Identification of mechanisms involved in the relaxation of rabbit cavernous smooth muscle by a new nitric oxide donor ruthenium compoundGnaphaliin A and B relax smooth muscle of guinea-pig trachea and rat aorta via phosphodiesterase inhibition
P2860
Q24236046-F058F48F-1E9D-4FC3-AFBD-873EFBABA01AQ24240809-52E43628-6DA1-42A6-A144-F3C857E18888Q28269129-DEE69095-E11A-4FEA-97F3-413B0834D792Q35000972-89D96B7F-4EDF-454F-A3F2-C039A5CEF04FQ35638042-FAE0734A-6C10-4866-905D-C85603C82794Q35741898-D1330025-A04F-47A6-88A0-B50DC82EEF25Q35750719-9FA3264B-47DA-48CC-8696-39865D733065Q35753433-534D1A83-3625-461D-9E38-DDE32B92932EQ35824111-90490663-6A64-4701-A538-2FFB9D4D70D3Q36572595-A0A3D9EF-98A2-4E1B-9B6A-89286957CB66Q43263739-6D070201-5944-498B-9A18-B0F523059BF3Q44257739-6C280E67-6E74-48D5-9F20-D7499B4B95B1Q53251470-0FDA39EF-D710-4C3E-AF3D-6A0E22F9FB91Q54966678-E86AB388-C364-4AB9-BA92-51E93E200B1DQ57099077-C583CEFE-9EAF-4E8E-B33E-49222CEC7EB8
P2860
Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Inhibition of cyclic GMP hydro ...... hodiesterase type 5 inhibitor.
@en
Inhibition of cyclic GMP hydro ...... hodiesterase type 5 inhibitor.
@nl
type
label
Inhibition of cyclic GMP hydro ...... hodiesterase type 5 inhibitor.
@en
Inhibition of cyclic GMP hydro ...... hodiesterase type 5 inhibitor.
@nl
prefLabel
Inhibition of cyclic GMP hydro ...... hodiesterase type 5 inhibitor.
@en
Inhibition of cyclic GMP hydro ...... hodiesterase type 5 inhibitor.
@nl
P2093
P1433
P1476
Inhibition of cyclic GMP hydro ...... phodiesterase type 5 inhibitor
@en
P2093
A M Traish
E Bischoff
I Goldstein
P304
P356
10.1016/S0024-3205(01)01308-X
P407
P50
P577
2001-09-01T00:00:00Z